|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,991.50 DKK | -0.92% |
|
-1.56% | +33.43% |
| 12-09 | BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours | MT |
| 12-09 | Genmab shares encouraging early-stage data on epcoritamab for RT patients | RE |
Chart calendar Genmab A/S
Upcoming events on Genmab A/S
| 11/12/2025 | R&D Day | Add to your calendar Google Apple ICS format |
| 04/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
| 18/03/2026 | Annual General Meeting | Add to your calendar Google Apple ICS format |
| 06/05/2026 | Q1 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 05/08/2026 | Q2 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 04/11/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 23/02/2027 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 11/05/2027 | Q1 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 11/08/2027 | Q2 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 09/11/2027 | Q3 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Genmab A/S
| 08/12/2025 | American Society of Hematology Meeting - Abstract No:5513 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No:5357 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No:5370 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No:5393 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No:5511 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No:1017 |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No:1015 |
| 07/12/2025 | American Society of Hematology Meeting - Abstract Number:3565 |
| 07/12/2025 | American Society of Hematology Meeting - Abstract No:4481 |
| 07/12/2025 | American Society of Hematology Meeting - Abstract No:3566 |
| 07/12/2025 | American Society of Hematology Meeting - Abstract No:3736 |
| 07/12/2025 | American Society of Hematology Meeting - Abstract No:466 |
| 07/12/2025 | American Society of Hematology Meeting - Abstract No:465 |
| 07/12/2025 | American Society of Hematology Meeting - Abstract No:464 |
| 06/12/2025 | American Society of Hematology Meeting - Abstract No:3565 |
| 06/12/2025 | American Society of Hematology Meeting - Abstract No:2721 |
| 06/12/2025 | American Society of Hematology Meeting - Abstract No:1960 |
| 06/12/2025 | American Society of Hematology Meeting - Abstract No:1959 |
| 06/12/2025 | American Society of Hematology Meeting - Abstract No:1955 |
| 06/12/2025 | American Society of Hematology Meeting - Abstract No:1820 |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 14 595 14 068 3.75% | 16 474 16 380 0.58% | 21 526 21 279 1.16% | 23 898 | 27 609 | 31 839 |
|
EBITDA Million DKK | Released Forecast Spread | 6 719 6 371 5.46% | 5 616 5 721 -1.83% | 7 116 6 933 2.64% | 8 984 | 10 158 | 12 866 |
|
EBIT Million DKK | Released Forecast Spread | 6 357 6 008 5.81% | 5 321 5 398 -1.42% | 7 003 6 441 8.72% | 8 451 | 8 887 | 11 242 |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 7 035 8 905 -21% | 5 637 6 236 -9.6% | 9 164 7 451 22.98% | 9 486 | 8 893 | 11 311 |
|
Net income Million DKK | Released Forecast Spread | 5 522 6 793 -18.71% | 4 352 4 989 -12.77% | 7 844 5 544 41.48% | 7 497 | 6 698 | 9 246 |
|
EPS DKK | Released Forecast Spread | 83,7 103 -18.98% | 66,0 76,1 -13.23% | 121 85,7 41.66% | 117 | 100 | 132 |
| Announcement Date | 22/02/23 | 14/02/24 | 12/02/25 | - |
Quarterly results
| Fiscal Period | June | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 4 678 4 610 1.48% | 4 143 3 989 3.86% | 5 402 4 959 8.94% | 9 545 9 039 5.6% | 5 540 5 646 -1.89% | 6 441 6 391 0.79% | 4 731 5 019 -5.73% | 5 934 5 812 2.11% | 6 613 6 373 3.77% | 6 579 | 6 133 | 6 800 | 7 334 | 7 213 |
|
EBITDA Million DKK | Released Forecast Spread | 1 899 1 804 5.28% | 823 880 -6.45% | 1 804 1 571 14.84% | 2 627 2 412 8.91% | 2 129 1 847 15.25% | 2 275 1 966 15.72% | 1 350 986 36.95% | 2 412 2 207 9.32% | 3 087 2 871 7.51% | 2 301 | 2 809 | 3 240 | 4 215 | |
|
EBIT Million DKK | Released Forecast Spread | 1 670 1 772 -5.73% | 801 832 -3.68% | 1 640 1 599 2.57% | 2 441 2 229 9.51% | 2 102 1 782 17.95% | 2 191 1 945 12.67% | 1 244 1 069 16.32% | 2 310 2 074 11.36% | 2 970 2 445 21.46% | 2 212 | 2 334 | 2 782 | 3 773 | |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 926 1 888 -50.95% | 1 716 1 064 61.28% | 2 127 1 847 15.15% | 3 843 3 374 13.9% | 1 719 1 761 -2.38% | 3 602 2 037 76.79% | 1 615 1 214 32.96% | 2 714 2 174 24.81% | 3 119 2 491 25.22% | 2 284 | ||||
|
Net income Million DKK | Released Forecast Spread | 640 1 439 -55.52% | 1 325 833 59.07% | 1 408 1 426 -1.28% | 2 733 2 598 5.2% | 1 266 1 373 -7.77% | 3 845 1 606 139.45% | 1 290 1 068 20.84% | 2 156 1 657 30.06% | 2 595 1 927 34.67% | 1 679 | 1 294 | 1 423 | 1 566 | 1 765 |
|
EPS DKK | Released Forecast Spread | 9,67 22,3 -56.65% | 20,2 12,9 56.06% | 21,7 21,8 -0.34% | 41,9 39,5 5.92% | 19,8 21,3 -6.93% | 59,6 25,0 138.85% | 20,2 16,0 26.14% | 34,8 24,5 42.1% | 41,8 30,3 37.77% | 27,4 | 14,8 | 14,6 | 20,7 | 22,6 |
| Announcement Date | 14/02/24 | 02/05/24 | 08/08/24 | 08/08/24 | 06/11/24 | 12/02/25 | 08/05/25 | 07/08/25 | 06/11/25 | - | - | - | - | - |
| 14/12/2025 | Q3 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 14/01/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 04/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 04/02/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 10/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 10/02/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 11/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 11/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past sector events for Genmab A/S
| 08/12/2025 | November 2025 Sales and Revenue Release | |
| 05/12/2025 | November 2025 Sales and Revenue Release | |
| 05/12/2025 | November 2025 Sales and Revenue Release | |
| 04/12/2025 | Q3 2025 Earnings Release | |
| 03/12/2025 | Q2 2026 Earnings Release (Projected) | |
| 25/11/2025 | Q4 2025 Earnings Release | |
| 21/11/2025 | Q3 2025 Sales and Revenue Release | |
| 17/11/2025 | Q3 2025 Earnings Release | |
| 14/11/2025 | Q3 2025 Earnings Release | |
| 13/11/2025 | Q3 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GMAB Stock
- Calendar Genmab A/S
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















